Abstract Background: Tuberculosis despite being treatable & preventable disease, it continues to be a major health challenge in many parts of the world. The emergence of drug-resistant tuberculosis has made the current epidemic worse.
Introduction
Tuberculosis is a global problem worldwide. About one third of the world's population are infected with mycobacterium tuberculosis or have active tuberculosis; making it the second leading infectious cause of death globally. In 2006; 9.2 million incident cases were reported and 1.2 million people died as a result of tuberculosis [1] . According to the WHO tuberculosis profile for Egypt in 2004; the prevalence rate of new cases of MDR-TB was 2.2%, while that of the previously treated tuberculous cases that were discovered to be multi drug-resistant was 38% [2] .
Methods
This retrospective study was conducted on 200 MDR-TB patients admitted to Abbassia Chest Hospital in the period between July 2006 and June 2010. Their files had been analyzed and the following data was collected: (1): full medical history; including age, sex, occupation, residence, special habits, history of previous anti-TB treatment, type of resistance either secondary (185 cases; 92.5%) or primary resistance (15 cases; 7.5%), history of previous anti-TB treatment regarding the place of treatment [hospital (74 cases; 37%), home (111 cases (55.5%) and 15 cases (7.5%) did not receive any anti-TB treatment], patients compliance [97 cases (48.5%) with irregular drug intake and 88 cases (44%) with regular drug intake], regimen of anti-TB treatment received [category 1: 2HRZE(S)/4HR, category 2: 2HRZES/1HRZE/5HR or both (failed category 1 and received category 2)] and the type of patients [treatment failure (88 cases; 44%), defaulters (89 cases; 44.5%), new cases (15 cases; 7.5%) or relapse (8 cases; 4%), (2) thorough general and local chest examination, (3) plain chest X-ray postero-anterior and lateral views, (4) routine laboratory investigations, (5) examination of sputum smears by ZN staining for three successive days, (6) sputum culture on Lowenstein-Jensen media, (7) drug regimens of resistance used according to drug sensitivity tests and past history of anti-TB drugs. The most frequently used regimen consisted of: 3 months: Kanamycin daily + Ofloxacin + Cycloserin + Ethionamide + PAS then; 6 months: Kanamycin 5 times a week + previous drugs then; 12 months:
Ofloxacin + Cycloserine + Ethionamide + PAS.
(8) fate of treatment: cure, treatment completed, death, treatment default, treatment failure or still on treatment.
Results
The current study included 200 MDR-TB patients, they were 148 males (74%) and 52 (26%) females. Their ages ranged from 15 to 76 years (37.83 ± 12.78 years) and males were significantly older than females [38.99 ± 12.01 versus 34.52 ± 14.36 years, (P < 0.05)]. Patients lived in rural areas were 81.5% and those lived in urban areas were 18.5% with insignificant difference between males and females regarding residence. Employed patients were 61.5% and the unemployed were 38.5%. The percentage of the employed males were significantly higher than the employed females (79.4% of males versus 13.5% of females, P < 0.001) ( Table 1) . Manual employment was more prevalent among males than females (82.2% versus 0%, P < 0.001) while professional employment was more prevalent among females than males (100% versus 20%, P < 0.001).
42.5% of the studied patients were tobacco smokers with significantly higher prevalence among males [56.8% of males versus 1.9% of females were tobacco smokers (P < 0.001)], 0.5% of the studied patients were drug addicts, 0.5% of them were alcoholics and 56.5% had no special habits of medical importance. Regarding the associated co-morbidities, 15% of the included patients were diabetics, 4% of them had liver diseases, 1.5% had GIT diseases, 1.5% had heart diseases and 1.5% had other lung diseases. No significant difference was found between males and females according to associated comorbidities.
Discussion
Males constituted 74% (148 cases) of patients included in this retrospective study while females were 26% (52 cases) ( Table 1 ). This coincides with the epidemiological picture of tuberculosis where males are more exposed to infection in the community than females because of occupational and mental stress or other social factors which prevent females from seeking medical advice, which may cause false lowering of the incidence rate in females [3] . The mean age was 37.38 ± 12.78 years, this age represents the period of physical, mental, and occupational stress. These results coincide with those found by Kamal [3] who reported that the mean age was 37.8 ± 11.7 years and males were 69.2% and females were 30.8%; Mohamed [4] who stated that the mean age was 36.7 ± 11.4 years and males were 74.3% and females were 25.7%; Fouad [5] who showed that the mean age was 30.29 ± 11.7 years and the percentage of males was 72.5% and that of females was 27.5%; and Abdel-Hamid [6] who found that the mean age was 35.92 ±11.66 years and males were 84% and females were 16%.
Our results showed that males were significantly older than females (38.99 ± 12.01 versus 34.5 ± 14.36 years). In disagreement with our results, Mohamed [4] found insignificant difference between males and females according to age. Also, 163 included patients (81.5%) lived in rural areas while those who lived in urban areas were 37 patients (18.5%). The difference between males and females according to the residence was statistically insignificant. These results were matched with those found by Fawzy [7] who reported that higher incidence of MDR-TB was found in patients living in rural areas (57.2%) compared to those living in urban areas (42.8%).
Regarding the employment, employed patients were 123 cases (61.5%) and the unemployed were 77 cases (38.5%) (Table 1), this is probably as employed patients are more liable to catch infection; 78.4% of males versus 13.5% of females were employed with a highly significant difference. These results were matched with Mohamed [4] who reported that employed patients were 76.1% and the unemployed were 23.9% of the studied patients. 91.6% of males versus 17.3% of females were employed with a highly significant difference.
The employed manual males were 96 patients (82.2%) but no manual workers were found among females. The employed professional females were 7 cases (100%) while the employed professional males were 20 cases (17.2%). The difference between males and females regarding the type of employment was highly significant. Coinciding with these results, Fawzy [7] stated that the manual workers had more MDR-TB than professional workers but no statistically significant difference was found.
The most frequent special habit of the studied patients was tobacco smoking that represented 42.5% of cases (85 cases). Drug addiction and alcohol intake represented an equal percentage of cases [0.5% of cases (one case) for each]. Tobacco smoking was more prevalent among males than females with a highly significant difference while no significant differences were found between males and females regarding alcohol intake or drug addiction.
These results were in agreement with Mohamed [4] who stated that in MDR-TB patients; smokers were 44.2% and non smokers were 55.8% and tobacco smoking was more prevalent among males than females with a highly significant difference. Higher percentages of smokers were found by Kamal [3] and Fawzy [7] who found that among MDR-TB patients; smokers were 61.53% and 56.4% while non smokers were 38.47% and 43.6%, respectively. No significant differences were found between males and females as regard smoking among the studied TB patients in both studies.
The most common co-morbidity associated with MDR-TB patients was diabetes mellitus [15% of the studied patients (30 cases)]. The second co-morbidity was liver disease; represented by 4% of patients (8 cases) . No statistically significant difference could be detected between males and females according to the associated co-morbidities. In agreement with these results, Mohamed [4] reported a higher frequency of diabetes mellitus [15% of the studied patients (17 cases)] than other co-morbidities in MDR-TB patients with no statistically significant difference between males and females as regards the associated co-morbidities. Also, Kamal [3] found that diabetic patients constituted 26.9% of the studied patients. A much higher percentage of diabetes mellitus was found by Fawzy [7] who reported that 80.7% of the studied MDR-TB patients were diabetics. Table 2 shows the history of previous anti-TB treatment among the studied patients; it revealed that defaulter patients were 44.5%, treatment failure patients were 44%, relapse patients were 4%, and new cases constituted 7.5% of the studied patients. This means that retreated patients were 92.5% and newly diagnosed patients were 7.5% of the studied group. Table 2 also shows that patients who received treatment at hospital were 74 cases (37%), those who received treatment at home were 111 cases (55.5%) and those who did not receive any treatment were 15 cases (7.5%). Patients who received category 1 treatment were 13 cases (6.5%), patients who received category 2 treatment were 172 cases (86%), and those who did not receive any anti-TB treatment were 15 cases (7.5%). According to the compliance, the table shows that there were 97 cases (48.5%) with irregular drug intake and 88 cases (44%) with regular drug intake. Lower percentages of defaulters, relapse patients and new cases and a higher percentage of treatment failure patients were found by Mohamed [4] who reported that defaulter patients were 33.6%, relapse patients were 0.9%, new cases were 4.4% and treatment failure patients were 61.1% of the studied patients. The mean retreated patients were 95.6% and the newly diagnosed patients were 4.4% of the studied patients. Also, Mohamed [4] found that the patients received category1 treatment were 7.1%, those who received category 2 treatment were 88.5%, and those who did not receive any treatment were 4.4% of the studied patients. There were 54.7% of patients with irregular drug intake and 40.9% with regular drug intake. Patients who received treatment at hospital were 79%, those who received treatment at home were 16.6%, and those who did not receive treatment were 4.4%. A higher percentage of new cases was found by Kamal [3] who reported that 46.2% of the studied MDR-TB patients were new cases while the defaulters were 19.2% and the relapse cases were 34.6% of the studied patients.
In Table 3 , acquired resistance was 92.5% and primary resistance was 7.5%. This might be due to lack of patients' adherence to chemotherapy or inappropriate regimens of treatment. These results coincided with those reported by AbdelHamid [6] who found that the acquired MDR-TB cases were higher than the primary MDR-TB cases (72% versus 28%). Table 4 shows that the percentages of resistance to Isoniazid, Rifampicin, Streptomycin and Ethambutol were 100%, 100%, 98.5% and 79.5%, respectively. In agreement with our results, Kamal [3] reported that the percentages of resistance to Isoniazid, Rifampicin, Streptomycin and Ethambutol were 100%, 100%, 80.8% and 38.5%, respectively. Also, Mohamed [4] stated that the percentages of resistance to Isoniazid, Rifampicin, Streptomycin and Ethambutol were 100%, 100%, 91.1% and 79.6% respectively. Lower results were reported by Fawzy [7] who found that the percentages of resistance to Isoniazid, Rifampicin, Streptomycin and Ethambutol were 54.5%, 52.2%, 40% and 28.4% respectively. These low percentages of resistance found by Fawzy [7] may be explained by the low percentage of MDR-TB patients included in this study [21 MDR-TB patients out of 128 studied TB patients (16.4%)] and this may give low presentative data. Table 5 shows that the duration for sputum conversion ranged from 2 to 9 months (4.19 ± 1.28 months). In agreement with these results, Mohamed [4] reported that the duration of sputum conversion was 5.5 ± 1.2 months. In Table 6; the fate of MDR-TB treatment was favorable outcome in 132 cases (66%), 28 patients were defaulters (14%), 21 patients died (10.5%) and 19 patients had treatment failure (9.5%). No significant difference could be detected between males and females according to the fate of treatment. In agreement with these results Masjedi et al. [8] reported that 67.5% of patients had successful outcome and 32.5% had poor outcome (treatment failure 14% and 18.5% died). Also, Helen et al. [9] reported that 62% of patients had successful treatment, 15% died, 14% were defaulters, and 8% of them had treatment failure. Worse outcome was noticed in the study done by Munsiff et al. [10] who reported that patients had successful outcome in 40% of cases, defaulters were 13% and 47% of patients were died.
In Table 7 ; the prevalence of defaulter patients was significantly higher among unfavorable outcome patients while the prevalence of treatment failure patients was significantly higher among favorable outcome. Table 8 shows that the most common complications were GIT manifestations in 88.5%, peripheral polyneuritis in 66%, hypothyroidism in 39.5%, depression in 26.5% and other complications as electrolytes disturbance, skin manifestations, arthralagia, and psychosis in 52.5% of patients. There was insignificant difference between males and females according to the frequency of drug complications.
Coinciding with our results, Mohamed [4] reported that the most frequent complications of anti-TB drugs were gastrointestinal manifestations in 84% then polyneuropathy in 57.5% of the studied patients. Also, Dhingra et al. [11] reported that in India the most frequent organs affected by anti TB drugs were the gastrointestinal tract in 53% of patients and the commonest presenting complaints were nausea and vomiting. Lastly, Kishore et al. [12] who reported that the adverse effects of anti-TB treatment were hepatobiliary in 57.1%, gastrointestinal in 14.3%, skeletal in 9.5%, cutaneous in 7.1%, renal in 4.8%, neurological in and ocular in 2.4%.
Conclusion
More than two thirds of Egyptian MDR-TB patients could be effectively treated and cured in Abbassia Chest Hospital. 
